tobacco | policy-forums | Knowledge Center

Substantial Equivalence Under the Family Smoking Prevention and Tobacco Control Act of 2009: How Can FDA Create a More Effective and Efficient Regulatory Scheme?

Posted on April 2013 by J. Benneville (Ben) Haas and Natalie N. Sanders

(A Response to Mark E. Greenwold’s ‘What Standards Should FDA Apply in Ruling on Applications for Substantial Equivalence for Tobacco Products Under the Family Smoking Prevention and To...read more

What Standards Should FDA Apply in Ruling on Applications for Substantial Equivalence for Tobacco Products Under the Family Smoking Prevention and Tobacco Control Act of 2009?

Posted on September 2012 by Mark Greenwold

by Mark Greenwold In this issue of the Policy Forum (Volume 2, Number 18, September 26, 2012) Mark Greenwold, Senior Consultant for the Campaign for Tobacco-Free Kids, discusses the Tobacco Control...read more

Will Public-Private Research Partnerships Improve Research Funding and Application?

Posted on March 2012 by James M. Solyst

James M. Solyst of ENVIRON International Corporation makes the argument that, at a time when federal budgets are precarious, the private sector must be prepared to continue to contribute to the sci...read more

Should Congress Amend Sections 911 and 916 of the Family Smoking Prevention and Tobacco Control Act to Improve Postmarket Surveillance of Modified Risk Tobacco Products?

Posted on February 2012 by Sam F. Halabi

Written by Sam F. Halabi, Assistant Professor of Law at the University of Tulsa, this Forum discusses what the author identifies as shortcomings in the current regulations governing modified risk t...read more

Are Misdemeanor Prosecutions Under the Park Doctrine an Effective Mechanism for Deterring Violations of the Federal Food, Drug, and Cosmetic Act?

Posted on July 2011 by Ariel Galsner

Does FDA Have Enough Funding to Fulfill Its Critical Role in Protecting the Public Health?

Posted on July 2011 by Lad Wiley, Steven A. Grossman

How Can the Federal Government Prevent Some Tobacco Product Manufacturers from Evading Taxes and Avoiding FDA Regulation?

Posted on May 2011 by Anne D. Spiggle

FDLI